All stock lists
Freenome, Inc. (NASDAQ:FRNM)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
12.58-0.19 (-1.49%)
Insider Score
––Not scored
FRNM Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
FRNM Income Statement
sourced directly from this company’s SEC filings (XBRL).
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 202552 weeks to date | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | — | — | — | — | — | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 941.33 K | — | 2.98 M | — | 193.20 K | — |
| R&D Expense | — | — | — | — | — | — |
| Operating Expenses | — | 858.83 K | — | 856.16 K | 193.20 K | 255.96 K |
| Operating Income | -941.33 K | -858.83 K | -1.68 M | -856.16 K | -193.20 K | -255.96 K |
| Pretax Income | — | — | — | — | — | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | -114.94 K | -51.75 K | -740.57 K | 144.63 K | 754.85 K | 678.55 K |
| EPS (Basic) | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — |
| Shares Outstanding | — | — | — | — | — | — |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.